Convalescent Antibodies Infusion in COVID 19 Patients

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 1, 2020

Primary Completion Date

September 21, 2022

Study Completion Date

September 21, 2022

Conditions
Pneumonia, ViralCorona Virus Infection
Interventions
BIOLOGICAL

Anti-coronavirus antibodies (immunoglobulins) obtained with DFPP form convalescent patients

Antibodies obtained from consenting convalescent donors will be administered to ten consecutive patients who fulfill the inclusion criteria .

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Aferetica

UNKNOWN

lead

Piero Luigi Ruggenenti

OTHER

NCT04418531 - Convalescent Antibodies Infusion in COVID 19 Patients | Biotech Hunter | Biotech Hunter